drugset

drugset / Trial / NCT01120821

Treatment of Polycythemia Vera With Gleevec

NCT01120821 ↗

Phase 2 Completed 36 enrolled Weill Medical College of Cornell University

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to evaluate the safety and effectiveness of patients with Polycythemia Vera treated with Gleevec.

Timeline

Start: 2002-08
Primary completion: 2007-01
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imatinib	Small molecule	400 mg	—

Indications